The impact of pulmonary arterial hypertension on idiopathic pulmonary fibrosis

Chest. 2007 Mar;131(3):641-3. doi: 10.1378/chest.07-0057.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiac Catheterization
  • Follow-Up Studies
  • Humans
  • Hypertension, Pulmonary / diagnosis*
  • Hypertension, Pulmonary / drug therapy
  • Hypertension, Pulmonary / mortality
  • Hypertension, Pulmonary / physiopathology
  • Phosphodiesterase Inhibitors / therapeutic use
  • Piperazines / therapeutic use
  • Prognosis
  • Pulmonary Diffusing Capacity / physiology
  • Pulmonary Fibrosis / diagnosis*
  • Pulmonary Fibrosis / drug therapy
  • Pulmonary Fibrosis / mortality
  • Pulmonary Fibrosis / physiopathology
  • Pulmonary Wedge Pressure / drug effects
  • Purines / therapeutic use
  • Sildenafil Citrate
  • Sulfones / therapeutic use
  • Survival Rate

Substances

  • Phosphodiesterase Inhibitors
  • Piperazines
  • Purines
  • Sulfones
  • Sildenafil Citrate